Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers
1996

Prognostic Value of Steroid Receptors in Breast Cancer

Sample size: 2257 publication Evidence: moderate

Author Information

Author(s): MF Pichon, P Broet, H Magdelenat, JC Delarue, F Spyratos, JP Basuyau, S Saez, A Rallet, P Courriere, R Millon, B Asselain

Primary Institution: Groupe de Biopathologie Tissulaire et Moleculaire, Federation des Centres de Lutte contre le Cancer

Hypothesis

The expression of oestrogen and progesterone receptors in primary breast tumors is related to patient outcomes.

Conclusion

Steroid receptor status has limited prognostic value compared to established criteria in early breast cancer.

Supporting Evidence

  • 68.8% of tumors were ER positive and 54.0% were PR positive.
  • Significant differences in overall survival were observed based on receptor status.
  • ER status lost its significance after 8 years of follow-up.

Takeaway

This study looked at how certain hormone receptors in breast cancer can help predict how well patients will do, but found that they aren't as helpful as other factors.

Methodology

A multicentric study followed 2257 operable breast cancer patients for a median of 8.5 years, measuring steroid receptor status and correlating it with clinical outcomes.

Potential Biases

Variability in patient demographics and treatment across different centers may introduce bias.

Limitations

The study relied on early steroid receptor assays, which may have selection bias due to technical requirements.

Participant Demographics

Mean age was 59 years, with 65% post-menopausal and 3.3% under 35 years.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication